Increased Dose in Spine Stereotactic Radiosurgery for Metastatic Disease: Are We Underestimating the Risks?
Abstract
Share and Cite
Kimchi, G.; Nulman, M.; Haj, S.; Bar-Orian, I.; Haisraely, O.; Harel, R. Increased Dose in Spine Stereotactic Radiosurgery for Metastatic Disease: Are We Underestimating the Risks? Medicina 2024, 60, 1514. https://doi.org/10.3390/medicina60091514
Kimchi G, Nulman M, Haj S, Bar-Orian I, Haisraely O, Harel R. Increased Dose in Spine Stereotactic Radiosurgery for Metastatic Disease: Are We Underestimating the Risks? Medicina. 2024; 60(9):1514. https://doi.org/10.3390/medicina60091514
Chicago/Turabian StyleKimchi, Gil, Maya Nulman, Saeda Haj, Idan Bar-Orian, Ory Haisraely, and Ran Harel. 2024. "Increased Dose in Spine Stereotactic Radiosurgery for Metastatic Disease: Are We Underestimating the Risks?" Medicina 60, no. 9: 1514. https://doi.org/10.3390/medicina60091514
APA StyleKimchi, G., Nulman, M., Haj, S., Bar-Orian, I., Haisraely, O., & Harel, R. (2024). Increased Dose in Spine Stereotactic Radiosurgery for Metastatic Disease: Are We Underestimating the Risks? Medicina, 60(9), 1514. https://doi.org/10.3390/medicina60091514